MyAverix Finance
F · Healthcare
Gyre Therapeutics, Inc. (L9S)
Biotechnology
Gyre Therapeutics, Inc. (L9S) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $634.48M, P/E ratio is 305.00, net margin is 4.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for L9S
Gyre Therapeutics, Inc. (L9S) — FAQ
What is Gyre Therapeutics, Inc.'s market cap?
Gyre Therapeutics, Inc. (L9S) has a reported market cap of $634.48M (data as of 2026-03-29).
What is L9S's P/E ratio?
The price-to-earnings (P/E) ratio for Gyre Therapeutics, Inc. (L9S) is 305.00 (data as of 2026-03-29).
Does Gyre Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Gyre Therapeutics, Inc. (L9S). Check the MyAverix Finance app for the latest dividend data.
What sector is Gyre Therapeutics, Inc. in?
Gyre Therapeutics, Inc. (L9S) is classified in the Healthcare sector (Biotechnology industry).
What exchange is L9S listed on?
L9S is listed on F.
What is Gyre Therapeutics, Inc.'s net margin?
Gyre Therapeutics, Inc. (L9S) reports a net margin of 4.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.